Related Experiment Video
Updated: Jul 2, 2026
10:10
Analyzing the Size, Shape, and Directionality of Networks of Coupled Astrocytes
Published on: October 4, 2018
Norepinephrine Couples Astrocytic Metabolism to mTOR-Driven Protein Synthesis
Florencia Cabrera-Cabrera1, Helena Tull1, Giulia Urone1
1Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.
Journal of Neurochemistry
|July 1, 2026
Summary
Norepinephrine stimulates protein synthesis in astrocytes via beta-adrenergic receptors and mTOR signaling. This process requires glycolysis and impacts astrocytic energy levels, revealing a new link between neuromodulation and cellular metabolism.
Area of Science:
- Neuroscience
- Cellular Metabolism
- Molecular Biology
Background:
- Norepinephrine is a key neuromodulator in the central nervous system.
- Astrocytic metabolism is influenced by norepinephrine, but its effect on protein synthesis is unknown.
Purpose of the Study:
- To investigate the role of norepinephrine in regulating protein synthesis in astrocytes.
- To elucidate the signaling pathways and metabolic requirements involved in this process.
Main Methods:
- Primary rat cortical astrocytes were used.
- Protein synthesis was measured following norepinephrine stimulation.
- Western blotting was employed to assess mTOR-S6K pathway activation.
- Glycolytic activity and ATP levels were monitored.
Main Results:
- Norepinephrine significantly stimulated protein synthesis in a time-dependent manner.
- The effect was primarily mediated by β-adrenergic receptors.
- Activation of the mTOR-S6K signaling pathway was observed.
- Glycolytic activity was essential, with preceding glycogen depletion and ATP reduction.
Conclusions:
- Norepinephrine is a potent stimulator of protein synthesis in astrocytes.
- This regulation involves the mTOR-S6K pathway and is dependent on glycolytic metabolism.
- These findings uncover a novel mechanism linking neuromodulatory signals, astrocyte metabolic state, and translational control.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...